The enzyme-linked immunosorbent assay (ELISA) testing market is representing impressive CAGR of 6.4% during the forecast period and to reach valuation US$ 4.02 billion by 2030.
The enzyme-linked immunosorbent assay (ELISA) testing market is representing impressive CAGR of 6.4% during the forecast period and to reach valuation US$ 4.02 billion by 2030.
The enzyme-linked immunosorbent assay (ELISA) testing is used to determine whether or not antibodies are present in a biological liquid sample. In various sectors, enzyme-linked immunosorbent assay (ELISA) testing is used as a quality assurance checks as well as a screening test tools in medicine and plant pathology.
The enzyme-linked immunosorbent assay (ELISA) testing is widely applicable in testing variety of chronic and infectious diseases. The HIV and AIDS can be treated with the help of enzyme-linked immunosorbent assay (ELISA) testing. According to World Health Organization (WHO), in 2020, 37.7 million people were suffering from HIV. As a result, the growing prevalence of HIV and AIDS is driving the growth of the global enzyme-linked immunosorbent assay (ELISA) testing market during the forecast period.
Get the sample copy of report@ https://www.precedenceresearch.com/sample/1260
In addition, the implementation of innovative and advanced technologies is propelling the demand for the enzyme-linked immunosorbent assay (ELISA) testing. Furthermore, the guidelines and strict rules and regulations imposed by government agencies is also driving the growth of the global enzyme-linked immunosorbent assay (ELISA) testing market.
However, the enzyme-linked immunosorbent assay (ELISA) testing cannot be afforded by each and every individual. So, this factor is hindering the growth of the global enzyme-linked immunosorbent assay (ELISA) testing market over the projected period. Moreover, the lack of proper resources in underdeveloped nations is also restricting the expansion of the enzyme-linked immunosorbent assay (ELISA) testing market. On the other hand, the government is taking constant efforts for the development of healthcare sector by providing enough subsidies and tax incentives for the growth and development of the enzyme-linked immunosorbent assay (ELISA) testing in the market. Thus, this factor is supporting the growth of the global enzyme-linked immunosorbent assay (ELISA) testing market.
Report Highlights:
- Based on the test type, the sandwich enzyme-linked immunosorbent assay (ELISA) segment dominated the global enzyme-linked immunosorbent assay (ELISA) testing market in 2020 with largest market share. The sandwich enzyme-linked immunosorbent assay (ELISA) test is one of the efficient types of tests carried out for diagnostics of certain chronic disorders.
- On the basis of application, the infectious diseasessegment holds the largest market share the global enzyme-linked immunosorbent assay (ELISA) testing market in 2020. The most common infectious diseases are HIV/AIDS, influenza, common cold, and chickenpox which can be tested with the help of enzyme-linked immunosorbent assay (ELISA) testing.
- North America is the largest segment for enzyme-linked immunosorbent assay (ELISA) testing market in terms of region. The expansion of healthcare sector and growing research and development activities are factors driving the growth of the enzyme-linked immunosorbent assay (ELISA) testingmarket in the region.
- Asia-Pacific region is the fastest growing region in the enzyme-linked immunosorbent assay (ELISA) testing market.The developing and developed countries of Asia-Pacific region such as Japan, China, and India and growing trend of medical tourism are contributing towards the growth of the enzyme-linked immunosorbent assay (ELISA) testingmarket over the forecast period.
Ask here for customization@ https://www.precedenceresearch.com/customization/1260
Future of Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market
The surge in applications of enzyme-linked immunosorbent assay (ELISA) testing in various types of diseases such as cancer and infectious disorders are boosting the growth of the global enzyme-linked immunosorbent assay (ELISA) testing market. Furthermore, the extensive research is being carried out for the development of technologies and software for enzyme-linked immunosorbent assay (ELISA) testing. Thus, this factor is going to create prospects for the growth of the global enzyme-linked immunosorbent assay (ELISA) testing market in the coming years.
COVID-19 Impact Analysis:
- The COVID-19 had a significant impact on the expansion and growth of the global enzyme-linked immunosorbent assay (ELISA) testing market.
- Due to coronavirus pandemic, the immunity of people started to decline. This is resulting in growing prevalence of wide range of chronic diseases.
- As a result, the effect of COVID-19 outbreak on the enzyme-linked immunosorbent assay (ELISA) testing was quite positive.
Key Developments in the Marketplace:
- The Native Antigen Company declared in January 2019 that the release of novel Zika immunoassays termed the NS1 enzyme-linked immunosorbent assay (ELISA) assay, which has remarkable specificity and sensitivity across a wide spectrum of biological samples.
- A University of Maryland and a University of Pennsylvania research team able to discover unexpected preterm birth clues in the cervicovaginal microbiome with an enzyme-linked immunosorbent assay (ELISA) test in March 2019, due to recent developments in enzyme-linked immunosorbent assay (ELISA).
- BARD1 Life Sciences is expected to push forward with the marketing of their BARD1-Ovarian blood-basedenzyme-linked immunosorbent assay (ELISA) test for the early detection of ovarian cancer in March 2018.
Major Market Segments Covered:
By Test Type
- Sandwich ELISA
- Indirect ELISA
- Multiple and Portable ELISA
- Competitive ELISA
- Others
By Application
- Immunology
- Inflammation
- Infectious diseases
- Cancer
- Protein quantification
- Other Applications
By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa (MEA)
Click Here to View Full Report Table of Contents
Buy this Research Report@ https://www.precedenceresearch.com/checkout/1260
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 9197 992 333